Normal Saxenda solution should be clear, colourless, and free from particles, cloudiness, or discolouration
Understanding variations and fluctuations in the concentrations of host or microbiota-derived metabolites that can be used to infer processes contributing to the symptoms and severity of IBS will provide important new insights for functional gastrointestinal disorders (FGDs) research
Social media intelligence adds further insight: patients most often cite tolerability issues as the primary reason for stopping GLP-1 treatment
This simple step can help you avoid issues related to decreased potency
The clinical significance of these interactions will be detailed in the prescribing information when orforglipron is approved, and is an important consideration for the many patients with obesity or type 2 diabetes who take multiple concurrent medications
One such study with semaglutide (generic drug name for Wegovy) found that on discontinuation of the medication, patients regained about two-thirds of their prior weight loss in just a year.* 2/3 of lost weight regained within one year of stopping semaglutide 2/3 of lost weight regained within one year of stopping semaglutide A similar study tested deprescribing of tirzepatide (generic drug name for Zepbound)
